Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this trial is to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of EHP-101 in adult subjects with diffuse cutaneous Systemic Sclerosis (dcSSc).
Epistemonikos ID: 2668440bf1260a9ab8096d3857bdf511be30e5b2
First added on: May 06, 2024